Literature DB >> 23970205

microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma.

Nan Ling1, Junyi Gu, Zhe Lei, Mengmeng Li, Jun Zhao, Hong-Tao Zhang, Xiangdong Li.   

Abstract

microRNAs (miRNAs) are short noncoding RNAs, which modulate the expression of numerous genes by targeting mRNAs. Numerous abnormal miRNA expression patterns are found in various human malignancies, and certain miRNAs act as oncogenes or tumor suppressors. microRNA-155 (miR‑155) may not only function as an oncogene but also as a tumor suppressor in various types of cancer cells, such as melanoma. Although miR-155 has been found to be upregulated in glioma, its role has not yet been eludicated in glioma tumorigenesis. Based on the prediction of the target genes of miR-155, we hypothesized that there is a significant association between miR-155 and FOXO3a, a negative regulator of Akt signaling. In the present study, we found that FOXO3a expression was significantly downregulated and miR-155 was upregulated in a panel of glioma cells and tissue specimens. Furthermore, we demonstrated that miR-155 induced cell proliferation by inhibiting apoptosis and promoted the migration and invasiveness of glioma cells, while miR-155 had no effect on the cell cycle as determined by gain-of-function and loss-of-function experiments. Moreover, we confirmed that miR-155 downregulated the expression of FOXO3a by directly targeting its 3'-UTR. These findings indicate that miR-155 may function as an oncogene by targeting FOXO3a in the development and progression of glioma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23970205     DOI: 10.3892/or.2013.2685

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  60 in total

1.  MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3.

Authors:  Huailei Liu; Chenguang Li; Chen Shen; Fei Yin; Kaikai Wang; Yaohua Liu; Bingjie Zheng; Weiguang Zhang; Xu Hou; Xin Chen; Jianing Wu; Xiaoxiong Wang; Chen Zhong; Jiakang Zhang; Huaizhang Shi; Jing Ai; Shiguang Zhao
Journal:  J Neurooncol       Date:  2015-02-27       Impact factor: 4.130

Review 2.  Posttranscriptional regulation of FOXO expression: microRNAs and beyond.

Authors:  P Urbánek; L-O Klotz
Journal:  Br J Pharmacol       Date:  2016-05-02       Impact factor: 8.739

Review 3.  FoxO3a and disease progression.

Authors:  Richard Seonghun Nho; Polla Hergert
Journal:  World J Biol Chem       Date:  2014-08-26

Review 4.  Role of miR-155 in drug resistance of breast cancer.

Authors:  Dan-dan Yu; Meng-meng Lv; Wei-xian Chen; Shan-liang Zhong; Xiao-hui Zhang; Lin Chen; Teng-fei Ma; Jin-hai Tang; Jian-hua Zhao
Journal:  Tumour Biol       Date:  2015-03-06

5.  Fine-tuning of FOXO3A in cHL as a survival mechanism and a hallmark of abortive plasma cell differentiation.

Authors:  Clarissa D Osswald; Linka Xie; Hanfeng Guan; Franziska Herrmann; Sarah M Pick; Marion J Vogel; Franziska Gehringer; Fong Chun Chan; Christian Steidl; Thomas Wirth; Alexey Ushmorov
Journal:  Blood       Date:  2018-02-13       Impact factor: 22.113

6.  Clinical significance of microRNA-155 expression in hepatocellular carcinoma.

Authors:  Chengnong Guan; Feng Yang; Xichun He; Tuhua Li; Qingmei Yang; Huiping He; Meng Xu
Journal:  Oncol Lett       Date:  2015-12-22       Impact factor: 2.967

7.  miR-155 Overexpression Promotes Genomic Instability by Reducing High-fidelity Polymerase Delta Expression and Activating Error-Prone DSB Repair.

Authors:  Jennifer R Czochor; Parker Sulkowski; Peter M Glazer
Journal:  Mol Cancer Res       Date:  2016-02-05       Impact factor: 5.852

8.  miR-155 contributes to the progression of glioma by enhancing Wnt/β-catenin pathway.

Authors:  Zhiyong Yan; Shusheng Che; Jianpeng Wang; Yingbing Jiao; Chao Wang; Qinghai Meng
Journal:  Tumour Biol       Date:  2015-02-12

9.  Overexpression of microRNA-155 predicts poor prognosis in glioma patients.

Authors:  Jun Sun; Huachao Shi; Niansheng Lai; Keman Liao; Shuai Zhang; Xiaojie Lu
Journal:  Med Oncol       Date:  2014-03-13       Impact factor: 3.064

10.  MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B.

Authors:  Jing Hu; Tao Sun; Hui Wang; Zhengxin Chen; Shuai Wang; Lifeng Yuan; Tingyu Liu; Hai-Ri Li; Pingping Wang; Yukuan Feng; Qinhong Wang; Roger E McLendon; Allan H Friedman; Stephen T Keir; Darell D Bigner; Jeff Rathmell; Xiang-Dong Fu; Qi-Jing Li; Huibo Wang; Xiao-Fan Wang
Journal:  Cancer Cell       Date:  2016-01-11       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.